VNUS Medical Technologies (VNUS) Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
More News related to VNUS
- Sidoti Starts VNUS Medical (VNUS) at Neutral
- VNUS Medical Technologies to Present at UBS Global Life Sciences Conference
- VNUS Medical Technologies (VNUS) Makes Corrections to Q2 Earnings; Updates Guidance
- VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
- Pre-Open Movers 7/30: Elan (ELN) Sinks On Drug Data; Buffalo Wild Wings (BWLD) Up on Results
More News related to Corporate News
- Constar International (CNST) Announces Four-Year Agreement with Pepsi (PEP); Undertakes Restructuring Plan
- SandRidge Energy (SD) Acquires Additional Interests and Terminates Executive Well Participation Plan
- Range Resources (RRC) Reports Record Production, 19% YoY Increase
- Oracle (ORCL) CEO Says May Take Advantage of Slowing Economy to Buy Other Companies -WSJ
- Lehman CDS Auction Sets Price of 8.625c on Bonds; Sellers of Swaps Would Pay 91.375c on the Dollar
VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) announced that it has asserted patent infringement claims in the United States District Court, Northern District of California, against biolitec Inc. (Biolitec), Dornier MedTech America, Inc. (Dornier) and NewStar Lasers, Inc. d/b/a CoolTouch, Inc. (CoolTouch).
Biolitec, CoolTouch and Dornier market endovenous laser ablation products for use in procedures which VNUS believes infringe several of its patents. VNUS is seeking an injunction prohibiting these companies from selling these products, in addition to monetary damages.
Related Categories
Corporate NewsStocks Mentioned
-0.32Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
